6-Fluoro-6-deoxy-D-glucose as a tracer of glucose transport.

Glucose transport rates are estimated noninvasively in physiological and pathological states by kinetic imaging using PET. The glucose analog most often used is (18)F-labeled 2FDG. Compared with glucose, 2FDG is poorly transported by intestine and kidney. We examined the possible use of 6FDG as a tracer of glucose transport. Lacking a hydroxyl at its 6th position, 6FDG cannot be phosphorylated as 2FDG is. Prior studies have shown that 6FDG competes with glucose for transport in yeast and is actively transported by intestine. Its uptake by muscle has been reported to be unresponsive to insulin, but that study is suspect. We found that insulin stimulated 6FDG uptake 1.6-fold in 3T3-L1 adipocytes and azide stimulated the uptake 3.7-fold in Clone 9 cells. Stimulations of the uptake of 3OMG, commonly used in transport assays, were similar, and the uptakes were inhibited by cyclochalasin B. Glucose transport is by GLUT1 and GLUT4 transporters in 3T3-L1 adipocyte and by the GLUT1 transporter in Clone 9 cells. Cytochalasin B inhibits those transporters. Rats were also imaged in vivo by PET using 6(18)FDG. There was no excretion of (18)F into the urinary bladder unless phlorizin, an inhibitor of active renal transport, was also injected. (18)F activity in brain, liver, and heart over the time of scanning reached a constant level, in keeping with the 6FDG being distributed in body water. In contrast, (18)F from 2(18)FDG was excreted in relatively large amounts into the bladder, and (18)F activity rose with time in heart and brain in accord with accumulation of 2(18)FDG-6-P in those organs. We conclude that 6FDG is actively transported by kidney as well as intestine and is insulin responsive. In trace quantity, it appears to be distributed in body water unchanged. These results provide support for its use as a valid tracer of glucose transport.

[1]  S M Partridge,et al.  Filter-paper partition chromatography of sugars: 1. General description and application to the qualitative analysis of sugars in apple juice, egg white and foetal blood of sheep. with a note by R. G. Westall. , 1948, The Biochemical journal.

[2]  W. Ford.  The effect of 6-deoxy-6-fluoroglucose on the fertility of male rats and mice. , 1982, Contraception.

[3]  P. Boyer,et al.  The effect of 6-deoxy-6-fluoro-d-glucose on yeast fermentation and on hexokinase. , 1955, Biochimica et biophysica acta.

[4]  S. Gatley.  Labeled glucose analogs in the genomic era. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  H. Vesselle,et al.  FDG PET of the retroperitoneum: normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls. , 1998, Radiographics : a review publication of the Radiological Society of North America, Inc.

[6]  J. Spencer,et al.  Inhibition of yeast metabolism by 2-deoxyglucose, 6-deoxy-6-fluoroglucose and the corresponding galactose derivatives. , 1966, Canadian journal of biochemistry.

[7]  O B Paulson,et al.  No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans. , 1999, Diabetes.

[8]  L. Nagy,et al.  Endothelin-1-stimulated glucose uptake is desensitized by tumor necrosis factor-alpha in 3T3-L1 adipocytes. , 2003, American journal of physiology. Endocrinology and metabolism.

[9]  L. Mortelmans,et al.  Synthesis and biologic evaluation of (11)c-methyl-d-glucoside, a tracer of the sodium-dependent glucose transporters. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  M. Blaufox,et al.  Optimization of urinary FDG excretion during PET imaging. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  Alessandra Bertoldo,et al.  Weight loss-induced plasticity of glucose transport and phosphorylation in the insulin resistance of obesity and type 2 diabetes. , 2003, Diabetes.

[12]  R. Viola,et al.  The use of fluoro- and deoxy-substrate analogs to examine binding specificity and catalysis in the enzymes of the sorbitol pathway. , 1998, Carbohydrate research.

[13]  F. Ismail-Beigi,et al.  Rapid activation of GLUT-1 glucose transporter following inhibition of oxidative phosphorylation in clone 9 cells. , 1993, The Journal of biological chemistry.

[14]  H. Levine,et al.  Action of insulin on distribution of glucose analogs in eviscerated-nephrectomized dogs. , 1958, The American journal of physiology.

[15]  B. Landau,et al.  SUGAR TRANSPORT AND FRUCTOSE METABOLISM IN HUMAN INTESTINE IN VITRO. , 1965, The Journal of clinical investigation.

[16]  B. Landau,et al.  Synthesis of [18F]‐6‐deoxy‐6‐fluoro‐D‐glucose ([18F]6FDG), a potential tracer of glucose transport , 2005 .

[17]  B. Landau,et al.  Hexose transport by hamster intestine in vitro. , 1962, The American journal of physiology.

[18]  R. Metzger,et al.  STUDIES WITH RAT LIVER GLUCOSE DEHYDROGENASE. , 1964, The Journal of biological chemistry.

[19]  B. Landau,et al.  Specificity of sugar transport by the intestine of the hamster. , 1960, The American journal of physiology.

[20]  A. N. Wick,et al.  Studies of 6-Deoxy-6-fluoroglucose and Insulin , 1959, Diabetes.

[21]  H. Malcolm Hudson,et al.  Accelerated image reconstruction using ordered subsets of projection data , 1994, IEEE Trans. Medical Imaging.

[22]  R. Wahl.  Targeting glucose transporters for tumor imaging: "sweet" idea, "sour" result. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  C. Cobelli,et al.  Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. , 1993, The Journal of clinical investigation.

[24]  A. N. Wick,et al.  Mechanism of Insulin Action , 1955, Diabetes.

[25]  F. Ismail-Beigi,et al.  Enhanced glucose transport in response to inhibition of respiration in Clone 9 cells. , 1989, The American journal of physiology.

[26]  P. K. Marsden,et al.  Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An [11C]-3-O-methyl-d-glucose PET study , 2005, Diabetologia.

[27]  L. Adler,et al.  Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer. , 1998, Clinical nuclear medicine.

[28]  L. D. Hall,et al.  2-Deoxy-2-fluoro-D-glucose , 1969 .

[29]  V. Courtenay,et al.  Some in vivo and in vitro antitumour effects of the deoxyfluoro-D-glucopyranoses. , 1973, European journal of cancer.

[30]  P. Perret,et al.  Assessment of insulin sensitivity in vivo in control and diabetic mice with a radioactive tracer of glucose transport: [125I]‐6‐deoxy‐6‐iodo‐D‐glucose , 2003, Diabetes/metabolism research and reviews.

[31]  F. Ismail-Beigi,et al.  Activation of Glut1 glucose transporter in response to inhibition of oxidative phosphorylation. , 1999, Archives of biochemistry and biophysics.

[32]  S. G. Reid,et al.  Filter-Paper Chromatography: Extraction of Sugars from the Paper at Room Temperature , 1950, Nature.

[33]  Alessandra Bertoldo,et al.  Dose-responsive insulin regulation of glucose transport in human skeletal muscle. , 2006, American journal of physiology. Endocrinology and metabolism.

[34]  D. Fagret,et al.  [123I]-6-deoxy-6-iodo-D-glucose (6DIG): a potential tracer of glucose transport. , 1997, Nuclear medicine and biology.